Upper gastrointestinal bleeding risk factors: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of upper gastrointestinal bleeding include: | |||
*Advancing age<ref name="pmid21341933">{{cite journal |vauthors=Morales Uribe CH, Sierra Sierra S, Hernández Hernández AM, Arango Durango AF, López GA |title=Upper gastrointestinal bleeding: risk factors for mortality in two urban centres in Latin America |journal=Rev Esp Enferm Dig |volume=103 |issue=1 |pages=20–4 |year=2011 |pmid=21341933 |doi= |url=}}</ref><ref name="pmid19744387">{{cite journal |vauthors=Rodríguez-Hernández H, Rodríguez-Morán M, González JL, Jáquez-Quintana JO, Rodríguez-Acosta ED, Sosa-Tinoco E, Guerrero-Romero F |title=[Risk factors associated with upper gastrointestinal bleeding and with mortality] |language=Spanish; Castilian |journal=Rev Med Inst Mex Seguro Soc |volume=47 |issue=2 |pages=179–84 |year=2009 |pmid=19744387 |doi= |url=}}</ref><ref name="pmid24108375">{{cite journal |vauthors=Corzo Maldonado MA, Guzmán Rojas P, Bravo Paredes EA, Gallegos López RC, Huerta Mercado-Tenorio J, Surco Ochoa Y, Prochazka Zárate R, Piscoya Rivera A, Pinto Valdivia J, De los Ríos Senmache R |title=[Risk factors associated to mortality by upper GI bleeding in patients from a public hospital. A case control study] |language=Spanish; Castilian |journal=Rev Gastroenterol Peru |volume=33 |issue=3 |pages=223–9 |year=2013 |pmid=24108375 |doi= |url=}}</ref><ref name="pmid5192276">{{cite journal |vauthors=Soldatov IB, Tokman AS, Esipovich IaN |title=[On the forms of dissemination of advanced experience of otorhinolaryngologists in dispensary work] |language=Russian |journal=Zdravookhr Ross Fed |volume=11 |issue=4 |pages=19–21 |year=1967 |pmid=5192276 |doi= |url=}}</ref> | |||
*Previous history of gastrointestinal bleed | |||
*Chronic kidney disease | |||
*Underlying cardiovascular disease | |||
*Cirrhosis and portal hypertension | |||
*Presence of H.pylori infection | |||
*NSAID's or aspirin use in patients with a history of ulcer disease | |||
*Patients on dual antiplatelet therapy | |||
*Age 60 years or older | |||
*Patients taking glucocorticoids | |||
*Dyspepsia | |||
*Gastroesophageal reflux disease | |||
*Nosocomial stress ulcers due the to the use of mechanical ventilation for more than 48 hours, and coagulopathy. | |||
*Rare conditions associated with gastric acid hypersecretion, such as Zollinger-Ellison syndrome, mastocytosis, or a retained antrum following partial gastrectomy. | |||
==References== | ==References== | ||
Revision as of 15:22, 6 November 2017
|
Upper gastrointestinal bleeding Microchapters |
|
Differentiating Upper Gastrointestinal Bleeding from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Management |
|
Surgery |
|
Case Studies |
|
Upper gastrointestinal bleeding risk factors On the Web |
|
American Roentgen Ray Society Images of Upper gastrointestinal bleeding risk factors |
|
Directions to Hospitals Treating Upper gastrointestinal bleeding |
|
Risk calculators and risk factors for Upper gastrointestinal bleeding risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arzu Kalayci, M.D. [2]
Overview
Risk Factors
Common risk factors in the development of upper gastrointestinal bleeding include:
- Advancing age[1][2][3][4]
- Previous history of gastrointestinal bleed
- Chronic kidney disease
- Underlying cardiovascular disease
- Cirrhosis and portal hypertension
- Presence of H.pylori infection
- NSAID's or aspirin use in patients with a history of ulcer disease
- Patients on dual antiplatelet therapy
- Age 60 years or older
- Patients taking glucocorticoids
- Dyspepsia
- Gastroesophageal reflux disease
- Nosocomial stress ulcers due the to the use of mechanical ventilation for more than 48 hours, and coagulopathy.
- Rare conditions associated with gastric acid hypersecretion, such as Zollinger-Ellison syndrome, mastocytosis, or a retained antrum following partial gastrectomy.
References
- ↑ Morales Uribe CH, Sierra Sierra S, Hernández Hernández AM, Arango Durango AF, López GA (2011). "Upper gastrointestinal bleeding: risk factors for mortality in two urban centres in Latin America". Rev Esp Enferm Dig. 103 (1): 20–4. PMID 21341933.
- ↑ Rodríguez-Hernández H, Rodríguez-Morán M, González JL, Jáquez-Quintana JO, Rodríguez-Acosta ED, Sosa-Tinoco E, Guerrero-Romero F (2009). "[Risk factors associated with upper gastrointestinal bleeding and with mortality]". Rev Med Inst Mex Seguro Soc (in Spanish; Castilian). 47 (2): 179–84. PMID 19744387.
- ↑ Corzo Maldonado MA, Guzmán Rojas P, Bravo Paredes EA, Gallegos López RC, Huerta Mercado-Tenorio J, Surco Ochoa Y, Prochazka Zárate R, Piscoya Rivera A, Pinto Valdivia J, De los Ríos Senmache R (2013). "[Risk factors associated to mortality by upper GI bleeding in patients from a public hospital. A case control study]". Rev Gastroenterol Peru (in Spanish; Castilian). 33 (3): 223–9. PMID 24108375.
- ↑ Soldatov IB, Tokman AS, Esipovich I (1967). "[On the forms of dissemination of advanced experience of otorhinolaryngologists in dispensary work]". Zdravookhr Ross Fed (in Russian). 11 (4): 19–21. PMID 5192276. Vancouver style error: initials (help)